Nearly all types of cancers have the potential to form metastatic growths. However, the exact moment when metastasis emerges is highly variable. While some patients develop metastatic disease soon after the primary tumour appears, others can see decades pass before it happens. What is the source of this variability? 

In this episode of the Zoom-In series, meet Maria Inês Romano. Curious about her work? Check out the Histopathology platform.

In this episode of the Zoom-In series, meet Tânia Mesquita, C-Care Team Coordinator at the Champalimaud Clinical Centre.

The CF is one of the Portuguese institutions whose projects were chosen as recipients of this first edition, for their capacitation efforts at the level of clinical research.

A diagnosis of breast cancer is not only an immediate life-threatening situation. It is also a psychological shock, whose repercussions can extend well past a patient’s recovery and jeopardise the leading of a normal life in the long run. However, not everyone reacts the same way to such a radical change of circumstances, which can imply invasive clinical interventions, radiotherapy and harsh chemotherapy regimens – and later strict surveillance to watch for recurrence.

This event, which was one of the first in the last 18 months to welcome back in-person participants as well as those online, had one question at its core: what do we need to know about digital health and patient-centred medicine?

"Art and science investigate the same fundamental questions - why are we here and how the world works. They also share the same basic approach - creative exploration. It is not surprising then that the benefits of the interactions between science and art are becoming increasingly more recognised", says Julia Salaroli, a professional dancer and choreographer who co-coordinates Bridges to the unknown - Crossing Art with Science with neuroscientist Patrícia Correia.

An interdisciplinary consortium of experts from Italy, Finland, Israel, Greece, and Portugal was formed in 2017 in response to a HORIZON 2020 call for Personalised Medicine research and innovation solutions. The product of this collaboration was BOUNCE, a funded project developed to explore factors that influence breast cancer patients’ long-term psychological resilience and their capacity to resume a normal everyday life and work, following breast cancer treatments. 

The ceremony marking the conclusion of the Botton-Champalimaud Pancreatic Cancer Centre was attended by the King and Queen of Spain, Felipe VI and Letizia, and the President of the Republic, Marcelo Rebelo de Sousa.